Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)

NAActive, not recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

March 3, 2025

Study Completion Date

May 31, 2026

Conditions
Metastatic Prostate Cancer (PCa) in ADTRehabilitation
Interventions
PROCEDURE

rehabilitation

The rehabilitation intervention will be led by a Physiotherapist and will include: a 12 weeks standardized multicomponent exercise (aerobic, resistance, balance and flexibility, and impact exercise if indicated), supervised by the physiotherapist, on an outpatient basis or in telerehabilitation. This program will be adapted to single patient needs. Every exercise session will last almost 60 minutes and patients will be supervised twice a week. One more exercise session per week will be self-managed by patients.

Trial Locations (1)

42123

SOC Oncologia Medica Provinciale, Reggio Emilia

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

NCT06238596 - Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) | Biotech Hunter | Biotech Hunter